AUSTIN, Texas, March 30, 2017 /PRNewswire/ -- If you're over 40 and starting to lose your crisp near vision, this message is for you. And while you may need your reading glasses to actually see this announcement, that may not be the case for long.
Always on the leading edge of what is new in vision correction technology, Mann Eye Institute has been involved from the start with the Raindrop Near Vision Inlay. Raindrop improves near vision in patients with presbyopia (over-40 vision).
The procedure, which received FDA approval last year, has helped patients worldwide regain their reading vision that can quickly deteriorate after age 40. The procedure is now available in the US, and Mann Eye Institute is the first to offer it in Austin, Texas.
"This technology allows us to help people with their focus and up-close vision," said Dr. Luke Barker, refractive surgeon at Mann Eye Institute in Austin. "It is for patients in their 40's and 50's who are frustrated with having to wear reading glasses, who hold the menu at arm's length just to be able to read it. The Raindrop Inlay is designed to address these frustrations. It restores a natural range of focus and near vision without compromising distance vision. Patients love it and we are so glad to be the first practice in Austin to offer this great option."
THE RAINDROP NEAR VISION INLAY:
- Restores focus and near vision without sacrificing distance vision
- Helps you see text messages and computer screens without the need for readers
- Improves near and intermediate vision by reshaping the front curvature of the cornea
To learn more about Mann Eye Institute or to schedule a consultation to see if you're a good candidate for the Raindrop Inlay, call 1 800 MY-VISION (698-4746) or visit MannEye.com.
Contact: Amanda Polk, Miller Public Relations
Phone #: (817) 281-3440
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mann-eye-institute-offers-whats-been-called-the-biggest-advancement-in-reading-vision-since-the-bifocal-300432083.html
SOURCE Mann Eye Institute